Eurobio Scientific Logo

Eurobio Scientific

Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.

ALERS | PA

Overview

Corporate Details

ISIN(s):
FR0004054435 (+2 more)
LEI:
969500IQEUEH806GE257
Country:
France
Address:
7 AVENUE DE SCANDINAVIE, 91940 LES ULIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Eurobio Scientific is an integrated specialty diagnostics company focused on developing, manufacturing, and distributing in-vitro diagnostic (IVD) tests and life sciences products for clinical use. The company's core areas of expertise are transplantation, infectious diseases, and oncology. Its portfolio includes a range of molecular diagnostics technologies, such as prognostic genomic tests for cancer, reagents and software for transplant matching, and genetic tests for various illnesses. Eurobio Scientific serves laboratories and healthcare providers, offering both its own proprietary solutions, which constitute a significant portion of its revenue, and products from partner companies through its distribution network.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-13 18:30
Interim / Quarterly Report
EUROBIO SCIENTIFIC : RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2025
French 947.6 KB
2025-09-24 17:40
Earnings Release
Eurobio Scientific : résultat du 1er semestre 2025
French 270.5 KB
2025-09-24 17:40
Earnings Release
EUROBIO SCIENTIFIC: RESULTS FOR THE FIRST SEMESTER OF FISCAL YEAR 2025
English 276.5 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific finalise l'acquisition de l'unité Sciences de la vie de Vod…
French 177.0 KB
2025-07-01 17:45
M&A Activity
Eurobio Scientific completes the acquisition of Life Science unit of Voden Med…
English 173.7 KB
2025-06-17 16:59
Major Shareholding Notification
Franchissement de seuils
French 116.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific : EB Development franchit à la hausse le seuil de 90%
French 135.1 KB
2025-05-19 19:16
Major Shareholding Notification
Eurobio Scientific: EB Development rises above 90% threshold
English 134.8 KB
2025-04-29 21:00
Report Publication Announcement
Eurobio Scientific: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2024
French 610.9 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific : RESULTAT ANNUEL 2024 - Croissance du cœur d’activité et dé…
French 216.3 KB
2025-04-28 17:46
Earnings Release
Eurobio Scientific: 2024 annual results
English 231.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC ÉTEND SA PRÉSENCE EN ITALIE
French 131.2 KB
2025-03-12 17:35
M&A Activity
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
English 133.7 KB
2025-03-04 20:03
Regulatory Filings
Eurobio Scientific : résiliation du contrat de liquidité
French 134.6 KB
2025-01-15 17:46
Report Publication Announcement
Eurobio Scientific : calendrier des publications financieres 2025
French 598.6 KB

Automate Your Workflow. Get a real-time feed of all Eurobio Scientific filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Eurobio Scientific

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Eurobio Scientific via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-12-18 N/A Other Buy 1,000 15,180.00 EUR

Peer Companies

Kodiak Sciences Inc. Logo
Developing durable biologics to treat high-prevalence retinal diseases and prevent blindness.
United States of America
KOD
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan
177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea
102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America
950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea
041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea
260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea
014570
South Korea
032300
KOREA UNITED PHARM INC Logo
South Korea
033270
Korro Bio, Inc. Logo
A clinical-stage biopharma using RNA editing to develop medicines for rare & prevalent diseases.
United States of America
KRRO

Talk to a Data Expert

Have a question? We'll get back to you promptly.